SYS · ONLINEPASS · 63.0%
Open Assay
Independent Testing / Est. 2026
BATCH04·26·B
PASS63.0%
N27
§ Corrections

Public correction log.

This page lists every change we make to previously published data, in reverse-chronological order. Corrections are added — they do not replace the original record. As a matter of policy, we do not silently remove published data.

Our four correction categories
Editorial
We caught our own mistake and fixed it. We own editorial errors directly — no soft framing, no passive voice.
Lab correction
A testing laboratory re-issued a COA with updated numbers. We publish both the original and the correction, with a note about what the lab said changed.
Vendor objection (sustained)
A vendor formally objected via our objection process, we investigated, and the evidence warranted a correction. Objections that are not sustained are not published here — but sustained ones always are.
Source retraction
A third-party source we cited (e.g., Finnrick, Janoshik) retracted or amended their data. We update our cited reference accordingly and document the chain.
§ 01

Corrections on record · 2

REVERSE-CHRONOLOGICAL
  1. April 21, 2026
    EDITORIAL
    Hero pass-rate displayed a placeholder 94% with no assays on file.

    The initial implementation of getSiteStats returned a fallback currentPassRate of 0.94 when samplesTested === 0, which the homepage LiveBatchCard surfaced as a giant "94%" number. This was a visually strong but materially misleading display — we hadn't run any assays yet and the number suggested we had. Fixed to default to 0 when samplesTested === 0, and downstream components (StatusStrip, SiteHeader KPI, LiveBatchCard gauge) now render em-dash / PENDING placeholders in the zero state.

    was: 94.0% pass rate (placeholder)now: — / PENDING until first blind-purchase assay runs

    Caught by the founder during live review. Fix shipped in commit 264ee74.

  2. April 21, 2026
    EDITORIAL
    Scope opened from "US research peptide suppliers" to global.

    Initial Open Assay positioning described our leaderboard as covering US-based suppliers only. On editorial review, this was judged to under-serve researchers who source internationally and to artificially exclude rigorous EU and Swiss vendors from consideration. Ownership, compliance, and editorial standards unchanged; only the geographic scope expanded.

    was: US peptide suppliersnow: research peptide suppliers worldwide

    Scope change also affected /vendors intake criteria and the /peptides/[slug] supplier aside copy. Non-US suppliers (QSC Peptides, Particle Peptides) were added as part of this change.

See something that looks wrong? Vendors can file formal objections via the objection process. Researchers, editors, and readers can email hello@openassay.org with a correction request. Include a permalink to the claim and any supporting evidence.